Intrinsic Value

The intrinsic value of Omnicell Inc (OC9) under the Base Case is 35.96 EUR per share. Compared with the current market price of 31.8 EUR, the stock appears Undervalued by 12% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

OC9 Intrinsic Value
€35.96
Undervaluation 12%
Intrinsic Value
Price €31.8

OC9 is cheaper than usual. It was this cheap or cheaper on just 21% of days in the past 5 years.

Monitor OC9
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €28.77
Get notified when the price drops into your buy zone
Intrinsic Value €35.96
Current Price €31.8
Margin of Safety 20% €28.77
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to OC9

Fundamental Analysis

What Omnicell Does

Health Care

Omnicell makes automation and software for hospitals, pharmacies, and health systems that need to store, track, dispense, and replenish medicines and other supplies. Its products include medication cabinets, robotics, packaging systems, and software that help nurses and pharmacists manage drugs more safely and with fewer manual steps. The company sits in the middle of the pharmacy supply chain, where accuracy and inventory control matter a lot.

Headquarters
United States of America US
Employees
3 580
IPO date
Aug 8, 2001
Read the full company overview
View Company Overview

Omnicell has no economic moat

No Moat Narrow Wide

Omnicell Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Omnicell Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

OMCL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one OC9 stock?

The intrinsic value for Omnicell Inc (OC9) under the Base Case is 35.96 EUR.

Is OC9 stock undervalued or overvalued?

Compared with the current market price of 31.8 EUR, the stock appears Undervalued by 12% .

Back to Top